Transcatheter embolization as the new reference standard for endoscopically unmanageable upper gastrointestinal...

Area of Science:

• Gastroenterology
• Interventional Radiology
• Surgical Gastroenterology

Background:

• Acute nonvariceal upper gastrointestinal bleeding (UGIB) presents significant morbidity and mortality.
• Endoscopy is the primary treatment, but 10-30% of patients experience rebleeding.
• Transcatheter angiographic embolization (TAE) and surgery are salvage options for failed endoscopic hemostasis.

Purpose of the Study:

• To compare the efficacy and safety of TAE versus emergency surgery for UGIB after failed endoscopic treatment.
• To analyze differences in rebleeding rates, mortality, complications, and length of stay.
• To define the role of TAE as a salvage therapy for acute nonvariceal UGIB.

Main Methods:

• Retrospective comparison of outcomes between TAE and surgery as salvage therapy for UGIB.
• Analysis of data from patients who underwent TAE or emergency surgery following unsuccessful endoscopic treatment.
• Evaluation of 30-day mortality, complication rates, rebleeding frequency, and length of hospital stay.

Main Results:

• No significant differences were observed in 30-day mortality, complication rates, or length of stay between TAE and surgery.
• Higher rates of rebleeding were noted in patients treated with TAE compared to surgery.
• Both TAE and surgery serve as viable salvage options following endoscopic treatment failure.

Conclusions:

• TAE is a valuable alternative to surgery for acute nonvariceal UGIB when endoscopic treatment fails.
• While rebleeding may be more frequent with TAE, overall outcomes are comparable to surgery.
• Further research is needed to fully delineate the optimal role and patient selection for TAE in UGIB management.